Initial Beneficial Ownership · 3
Century Therapeutics, Inc.
IPSCNASDAQEQUITYCurrent
Initial Beneficial Ownership
Structured filing — 3
form3-09102026_090934.xml
Filing details
- Report period
- 2026-09-09
- Issuer
- Century Therapeutics, Inc.
- Issuer CIK
- 0001850119
- Trading symbol
- IPSC
- No securities owned
- Checked
Reporting owner 1
- Name
- Truitt Joseph
- Reporting owner CIK
- 0001452429
- Relationship
- Director
- Address
- C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA, 19104
Remarks
Exhibit 24 - Power of Attorney
Signature 1
- Signed
- /s/ Douglas Carr, Attorney-in-Fact
- Date
- 2026-09-10
Filed exhibits
- EX-24 ↗ex24-09102026_090937.htm
Company context
Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of iPSC-derived cell therapies with the potential to meaningfully address autoimmune diseases, including T1D, and cancer. Century's therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics, please visit www.centurytx.com and connect with us on LinkedIn.